Avenge Bio Overview
- Year Founded
-
2019
- Status
-
Out of Business
- Employees
-
26
- Latest Deal Type
-
Out of Business
Avenge Bio General Information
Description
Developer of therapeutics designed to potentially eradicate intractable solid tumors. The company is developing a platform for the precision delivery of cytokines and other potent immunomodulatory molecules for a controlled period of time, enabling users to generate robust, local and systemic anti-tumor immune responses, without the toxicities associated with traditional immunotherapies.
Contact Information
Website
www.avengebio.comCorporate Office
- 22 Strathmore Road
- Suite 241
- Natick, MA 01760
- United States
Corporate Office
- 22 Strathmore Road
- Suite 241
- Natick, MA 01760
- United States
Avenge Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 01-Aug-2024 | Completed | Out of Business | |||
| 2. Early Stage VC (Series A) | 05-Jan-2022 | Completed | Pre-Clinical Trials | |||
| 1. Seed Round | 31-Mar-2020 | $5.2M | $5.2M | Completed | Stealth |
Avenge Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | ||||||||
| Series A-1 | ||||||||
| Seed | 4,171,839 | $0.000100 | 8% | $1.25 | $1.25 | 1x | $1.25 | 15.69% |
Avenge Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Avenge Bio Patents
Avenge Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230320346-A1 | Encapsulated cells and methods of preserving thereof | Inactive | 12-Apr-2022 | ||
| WO-2023201258-A2 | Encapsulated cells and methods of preserving thereof | Inactive | 12-Apr-2022 | ||
| WO-2023201258-A3 | Encapsulated cells and methods of preserving thereof | Inactive | 12-Apr-2022 | A01N1/125 |
Avenge Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Avenge Bio FAQs
-
When was Avenge Bio founded?
Avenge Bio was founded in 2019.
-
Where is Avenge Bio headquartered?
Avenge Bio is headquartered in Natick, MA.
-
What is the size of Avenge Bio?
Avenge Bio has 26 total employees.
-
What industry is Avenge Bio in?
Avenge Bio’s primary industry is Drug Discovery.
-
Is Avenge Bio a private or public company?
Avenge Bio is a Private company.
-
What is Avenge Bio’s current revenue?
The current revenue for Avenge Bio is .
-
How much funding has Avenge Bio raised over time?
Avenge Bio has raised $50.2M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
